Findings

What do systematic reviews say?

5 questions · 5 findings · 4 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 5 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Hypocaloric nutrition vs control

Mortality at 30 days: 28 to 30 days all‐cause mortality · critically ill adult patients

1 finding from 1 review

Prescribed hypocaloric nutrition support for critically‐ill adults 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 2611 participants
Very low

Antithrombin vs placebo

Neonatal mortality · very preterm infants at risk of intraventricular hemorrhage

It is very uncertain whether antithrombin changes neonatal mortality (all‐cause, < 28 days of age) compared with placebo (very low certainty).

1 finding from 1 review

Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants 2016 · Cochrane Headline outcomes only
RR 2 [0.62, 6.45]
2 studies · 182 participants
Very low

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

All‐cause mortality at 30 days · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people… 2018 · Cochrane Headline outcomes only
RR 0.94 [0.44, 1.99]
4 studies · 496 participants
Very low

Intervention not reported

All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…

It is very uncertain whether the intervention changes all‐cause mortality at 31 to 100 days (very low certainty).

1 finding from 1 review

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
RR 1 [0.27, 3.7]
3 studies · 451 participants
Very low

Intervention not reported

All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…

1 finding from 1 review

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 84 participants
Very low